Aidapak Recalls Minocycline Capsules Due to Potential Label Mixup
Aidapak Services, LLC is recalling Minocycline HCL capsules that may have been mislabeled as Progesterone. The repacked drugs were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall with potential for adverse health consequences (such as taking the wrong medication) corresponds to a severity score of 4 (Severe).
Plain-English summary
Aidapak Services, LLC is recalling Minocycline HCL, Capsule, 100 mg (NDC 00591569550) due to a potential label mixup. The source text indicates that the Minocycline capsules may have been mislabeled as Progesterone, Capsule, 100 mg (NDC 00591396401). The affected Minocycline product has the pedigree AD73611_10 and an expiration date of 5/30/2014.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall is classified as FDA Class II, which indicates that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers and healthcare providers should check their inventory for Minocycline HCL capsules with the specified pedigree and expiration date. If found, they should stop using the product and contact the recalling firm or their supplier for instructions on return or disposal.
The recalled product
- Product
- MINOCYCLINE HCL, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591569550.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Affected units
- 50
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- MINOCYCLINE HCL
- Capsule
- 100 mg has the following codes: Pedigree: AD73611_10
- EXP: 5/30/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
Similar recalls
- SevereAidapak Recalls Selegiline HCL Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Doxycycline Capsules Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Propranolol HCL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereFDA Recalls Misoprostol Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Trimethobenzamide Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22